HIV/エイズ診断薬市場：製品タイプ、検査タイプ、エンドユーザー別-2025-2030年の世界予測

HIV/エイズ診断薬市場は、2023年に68億4,000万米ドルと評価され、2024年には74億6,000万米ドルに達すると予測され、CAGR 9.12％で成長し、2030年には126億2,000万米ドルに達すると予測されています。

HIV/エイズ診断薬市場には、HIV感染の検出とモニタリングに使用されるさまざまな検査やツールが含まれ、これには抗体・抗原検査、ウイルス負荷検査、CD4検査などが含まれます。これらの診断の必要性は、患者の転帰を改善し、疾患の進行を防ぐために、HIVの早期発見とモニタリングが極めて重要であることから生じています。用途は主に、病院、診療所、診断研究所などのヘルスケア環境に及ぶ。最終用途の範囲は、より高度な診断技術の開発に重点を置く研究機関にも広がっています。市場の成長は、HIV早期発見の重要性に対する認識の高まり、世界のHIV感染率の上昇、より迅速で正確な検査を可能にする技術の進歩によって大きく左右されます。新たな機会は、資源が限られた環境で重要な迅速結果を提供するポイントオブケア検査のような分野にあります。デジタルヘルスと遠隔医療の台頭は、モバイル診断を統合してより幅広いアクセスを可能にする機会を提供します。しかし、HIV検査にまつわる偏見、規制上のハードル、高度な診断法の高コストなどの制約があり、普及の妨げとなっています。低コストで迅速な検査の開発や、HIV診断における解釈精度と予測分析のための人工知能の統合といった分野では、技術革新が熟しています。事業成長のためには、特に十分なサービスを受けていない地域における検査アクセスの拡大や、費用対効果の高い診断ソリューションの開発に投資することが推奨されます。この市場は、個別化医療と精密診断に向けた動向を背景に、継続的な研究開発努力が特徴となっています。潜在的な可能性は大きいが、競合情勢を乗り切り、持続的な成長を達成するためには、厳格な品質と倫理基準を維持することが極めて重要となります。

市場力学：急速に進化するHIV/エイズ診断薬市場の主要市場インサイトを公開

HIV/エイズ診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • HIV啓発のための政府イニシアチブの増加
  • 世界人口のHIV有病率
  • 核酸検査に対する高い嗜好性
• 市場抑制要因
  • 核酸検査（NAT）の高コスト
• 市場機会
  • 新しい治療法を模索する高度な診断法
  • 乳幼児のHIV早期診断のための革新的技術
• 市場の課題
  • 不正確な検査結果に関する懸念

ポーターの5つの力：HIV/エイズ診断薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：HIV/エイズ診断薬市場における外部からの影響の把握

外部マクロ環境要因は、HIV/エイズ診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析HIV/エイズ診断薬市場における競合情勢の把握

HIV/エイズ診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスHIV/エイズ診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、HIV/エイズ診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨HIV/エイズ診断薬市場における成功への道筋を描く

HIV/エイズ診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • HIV啓発のための政府の取り組みの強化
    • 世界中の人口におけるHIVの蔓延率
    • 核酸検査への高い関心
  • 抑制要因
    • 核酸検査（NAT）の高コスト
  • 機会
    • 新たな治療法を模索する高度な診断方法
    • 乳児のHIV早期診断のための革新的技術
  • 課題
    • 不正確な検査結果に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 HIV/エイズ診断薬市場：製品タイプ別

• 機器
• キットと試薬

第7章 HIV/エイズ診断薬市場テストタイプ別

• エリサ
• 核酸検査
• ラピッドテスト

第8章 HIV/エイズ診断薬市場：エンドユーザー別

• 学術調査機関
• 病院
• 民間診断研究所

第9章 南北アメリカのHIV/エイズ診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のHIV/エイズ診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのHIV/エイズ診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Alere Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Chembio Diagnostic Systems Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• OraSure Technologies, Inc.
• Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. HIV OR AIDS DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HIV OR AIDS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HIV OR AIDS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HIV OR AIDS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HIV OR AIDS DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. HIV OR AIDS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. HIV OR AIDS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The HIV or AIDS Diagnostics Market was valued at USD 6.84 billion in 2023, expected to reach USD 7.46 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 12.62 billion by 2030.

The HIV or AIDS diagnostics market encompasses the various tests and tools used to detect and monitor HIV infection, which includes antibody and antigen tests, viral load tests, CD4 tests, and others. The necessity of these diagnostics arises from the critical need for early detection and monitoring of HIV to enhance patient outcomes and prevent disease progression. Applications predominantly span healthcare settings, including hospitals, clinics, and diagnostic laboratories. End-use scope extends to research institutes focusing on the development of enhanced diagnostic technologies. Market growth is significantly influenced by increased awareness of the importance of early HIV detection, a rise in global HIV prevalence, and advancements in technology that enable quicker and more accurate testing. Emerging opportunities lie in areas like point-of-care testing, which provides rapid results, critical in resource-limited settings. The rise of digital health and telemedicine presents an opportunity to integrate mobile diagnostics for wider accessibility. However, the market faces limitations, such as stigma associated with HIV testing, regulatory hurdles, and the high cost of advanced diagnostic methods, which can impede widespread adoption. Innovation is ripe in areas such as the development of low-cost, rapid tests, and integration of artificial intelligence for interpretative accuracy and predictive analytics in HIV diagnostics. For business growth, companies are recommended to invest in expanding testing accessibility, especially in underserved areas, and in developing cost-effective diagnostic solutions. The market is characterized by continuous research and development efforts, with a trend towards personalized medicine and precision diagnostics. While the potential is significant, maintaining rigorous quality and ethical standards will be crucial in navigating the competitive landscape and achieving sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving HIV or AIDS Diagnostics Market

The HIV or AIDS Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing government initiatives for HIV awareness
  • Prevalence of HIV among population worldwide
  • High preference for Nucleic acid tests
• Market Restraints
  • High cost of Nucleic acid tests (NAT)
• Market Opportunities
  • Advanced diagnostic methods exploring new ways of treatment
  • Innovative technologies for early infant diagnosis of HIV
• Market Challenges
  • Concerns related to inaccurate test results

Porter's Five Forces: A Strategic Tool for Navigating the HIV or AIDS Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the HIV or AIDS Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the HIV or AIDS Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the HIV or AIDS Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the HIV or AIDS Diagnostics Market

A detailed market share analysis in the HIV or AIDS Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the HIV or AIDS Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the HIV or AIDS Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the HIV or AIDS Diagnostics Market

A strategic analysis of the HIV or AIDS Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the HIV or AIDS Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., OraSure Technologies, Inc., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the HIV or AIDS Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Instruments and Kits & Reagents.
• Based on Test Type, market is studied across ELISA, Nucleic Acid Tests, and Rapid Tests.
• Based on End User, market is studied across Academic & Research Institutes, Hospitals, and Private Diagnostics Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing government initiatives for HIV awareness
    • 5.1.1.2. Prevalence of HIV among population worldwide
    • 5.1.1.3. High preference for Nucleic acid tests
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of Nucleic acid tests (NAT)
  • 5.1.3. Opportunities
    • 5.1.3.1. Advanced diagnostic methods exploring new ways of treatment
    • 5.1.3.2. Innovative technologies for early infant diagnosis of HIV
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to inaccurate test results
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. HIV or AIDS Diagnostics Market, by Product Type

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits & Reagents

7. HIV or AIDS Diagnostics Market, by Test Type

• 7.1. Introduction
• 7.2. ELISA
• 7.3. Nucleic Acid Tests
• 7.4. Rapid Tests

8. HIV or AIDS Diagnostics Market, by End User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Hospitals
• 8.4. Private Diagnostics Laboratories

9. Americas HIV or AIDS Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific HIV or AIDS Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa HIV or AIDS Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alere Inc.
• 3. Becton Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Chembio Diagnostic Systems Inc.
• 6. Danaher Corporation
• 7. F. Hoffmann-La Roche Ltd.
• 8. Hologic, Inc.
• 9. OraSure Technologies, Inc.
• 10. Siemens Healthineers AG